Drug Detail

Information about BAY80-6946

Generic Name
IND
BAY80-6946
Brand Name (US)
Manufacturer
Bayer
Drug Type
Delivery
Intravenous
Approval Status
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block related tumor signal paths
Drug Category
PI3K inhibitor


Links


Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed